Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zegerid vs Prilosec OTC Pharmacodynamic Study
NCT00674115Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Bayer. Started Apr 2008; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00674115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674115.